Inactive Instrument

SDS Biotech K.K.

4952

JP3163200003

SDS Ramcides Cropscience Private Limited announced that it expects to receive INR 1.32 billion in funding from SDS Biotech K.K.

March 12, 2018

Sree Ramcides Chemicals Pvt Ltd. announced that it will issue 1,320,000,000 common shares at a price of INR 1 per share for gross proceeds of INR 1,320,000,000 from SDS Biotech K.K. (TSE:4952) on March 13, 2018. The company transaction is expected to close on March 15 2018. The transaction was approved by the board of directors of SDS Biotech K.K. (TSE:4952).

Latest news about SDS Biotech K.K.

Idemitsu Kosan Co.,Ltd. completed the acquisition of remaining 30.3% stake in SDS Biotech K.K. from group of sellers.	21-07-27	CI
Idemitsu Kosan Co.,Ltd. entered into Share Exchange Agreement to acquire remaining 30.3% stake in SDS Biotech K.K. from group of sellers for ¥3.1 billion.	21-05-10	CI
SDS Biotech K.K. Reports Earnings Results for the Second Quarter of 2021	20-11-27	CI
SDS Biotech K.K. Announces Consolidated Financial Results for the Nine Months Ended December 31, 2019; Provides Consolidated Financial Guidance for the Year Ending March 31, 2020	20-02-05	CI
SDS Biotech K.K. Announces Consolidated Earnings Results for the First Quarter Ended June 30, 2019; Provides Earnings Guidance for the Full Year Ending March 31, 2020; Provides Dividend Guidance for the Second Quarter of Fiscal Year 2020 and Full Year Ending March 31, 2020	19-07-30	CI
Sds Biotech K.K. Announces Consolidated Earnings Results for the Year Ended March 31, 2018	18-05-14	CI
R.Narasimhan, R.Padmanaban, R.Gopal completed the acquisition of an additional 97.95% stake in SDS Ramcides Cropscience Private Limited from SDS Biotech K.K..	18-03-26	CI
SDS Ramcides Cropscience Private Limited announced that it expects to receive INR 1.32 billion in funding from SDS Biotech K.K.	18-03-12	CI
R.Narasimhan, R.Padmanaban, R.Gopal entered into an agreement to acquire additional 97.95% stake in SDS Ramcides Cropscience Private Limited from SDS Biotech K.K. for INR 0.21 million.	18-03-12	CI
SDS Biotech K.K. Announces Consolidated Earnings Results for the Third Quarter Ended December 31, 2017; Provides Consolidated Earnings Guidance for the Full Year Ending March 31, 2018; Provides Dividend Guidance for the Year Ending March 31, 2018	18-02-05	CI
SDS Biotech K.K. Reports Consolidated Earnings Results for the Six Months Ended September 30, 2017; Provides Earnings Guidance for the Fiscal Year Ending March 31, 2018	17-11-01	CI
SDS Biotech K.K. Announces Consolidated Earnings Results for the First Quarter Ended June 30, 2017; Provides Consolidated Earnings Guidance for the Full Year Ending March 31, 2018; Provides Dividend Guidance for the Second Quarter and Full Year of Fiscal 2018	17-08-02	CI
SDS Biotech K.K. Reports Consolidated and Non-Consolidated Earnings Results for the Year Ended March 31, 2017; Announces Dividend for the Year Ended March 31, 2017, Payable on June 29, 2017; Provides Earnings Guidance for the Year Ending March 31, 2018; Provides Dividend Guidance for the Second Quarter and Fiscal Year 2018	17-05-11	CI
SDS Biotech K.K. Reports Consolidated Earnings Results for the Third Quarter Ended December 31, 2016; Revised Consolidated Earnings Guidance for the Full Year Ending March 31, 2017; Provides Dividend Guidance for the Full Year Ending March 31, 2017	17-02-06	CI
SDS Biotech K.K. Reports Consolidated Earnings Results for the Six Months Ended September 30, 2016; Provides Consolidated Earnings Guidance for the Year Ending March 31, 2017	16-10-31	CI
SDS Biotech K.K. Reports Consolidated Earnings Results for the First Quarter Ended June 30, 2016; Provides Earnings Guidance for the Fiscal Year Ending March 31, 2017	16-08-01	CI
SDS Biotech K.K. Reports Consolidated Earnings Results for the Period Ended December 31, 2015; Provides Consolidated Earnings Guidance for the Full Year Ending March 31, 2016; Provides Dividend Guidance for the Full Year Ending March 31, 2016	16-02-01	CI
SDS Biotech K.K. Reports Consolidated Earnings Results for the Nine Months Ended September 30, 2015; Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2016; Provides Dividend Guidance for the Year Ended March 31, 2016; Announces Change in Fiscal Year from December 31 to March 31	15-11-04	CI
SDS Biotech K.K. Reports Consolidated Earnings Results for the Second Quarter Ended June 30, 2015; Provides Consolidated Earnings Guidance and Dividend Guidance for the Fiscal Year Ending March 2016	15-08-03	CI
SDS Biotech K.K. Reports Consolidated Earnings Results for the First Quarter Ended March 31, 2015; Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 2016	15-04-30	CI
SDS Biotech K.K. Revises Consolidated and Non-Consolidated Earnings Guidance for the Year Ended December 31, 2014	15-01-25	CI
SDS Biotech K.K. Reports Consolidated Earnings Results for the Nine Months Ended September 30, 2014; Provides Consolidated Earnings Guidance for the Full Year Ending December 31, 2014; Provides Dividend Guidance for the Full Year Ending December 31, 2014	14-11-04	CI
SDS Biotech K.K. Reports Consolidated Earnings Results for the Six Months Ended June 30, 2014; Provides Earnings Guidance for Full Year Ending December 31, 2014; Announces Dividend for the Second Quarter Ended June 30, 2014, Payable on September 8, 2014; Provides Dividend Guidance for the Ending December 31, 2014	14-08-07	CI
SDS Biotech K.K. Announces Consolidated Earnings Results for the First Quarter Ended March 31, 2014; Provides Earnings Guidance for the Year Ending December 31, 2014	14-05-08	CI
Jiangsu Xinyi Taihe Chemical Co., Ltd. announced that it has received CNY 13.31 million in funding from SDS Biotech K.K.	14-04-16	CI

Chart SDS Biotech K.K.

Duration

Period

More charts

Company Profile

SDS Biotech KK is a Japan-based company mainly engaged in the research, development, manufacture and sale of agricultural chemicals made by combining active ingredient, original substance and auxiliary ingredient into powder, granule, liquid and other dosage forms. The products include fungicides, rice herbicides, greening related agents and insecticides. Fungicides are drugs that protect crops from harmful effects of filamentous fungi, bacteria and other phytopathogenic fungi. Rice herbicide is a herbicide used for controlling weeds and rice cultivation. Greening related agents are drugs used in golf courses and parks, herbicides used in upland fields, and plant growth regulators that enhance or inhibit the physiological functions of plants. Insecticides are agents used to control insect pests that damage crops. The Company also provides industrial fungicides. The Company operates within the domestic market and to overseas markets, including Asia, North America, Europe and Oceania.

Sector

Agricultural Chemicals

More about the company

Sector Pesticide

	1st Jan change	Capi.
JIANGSU YANGNONG CHEMICAL CO., LTD.	-10.11%	3.2B
SHANDONG WEIFANG RAINBOW CHEMICAL CO., LTD	-36.87%	1.68B
ANHUI GUANGXIN AGROCHEMICAL CO., LTD.	-14.83%	1.53B
ADAMA LTD.	-30.98%	1.43B
ZHEJIANG XINAN CHEMICAL INDUSTRIAL GROUP CO.,LTD	-14.14%	1.41B
NUFARM LIMITED	-11.49%	1.19B
SHENZHEN NOPOSION CROP SCIENCE CO., LTD.	-7.14%	1.03B
DHANUKA AGRITECH LIMITED	+57.75%	931M
LIER CHEMICAL CO.,LTD.	-31.16%	893M

Pesticide